Neuraxpharm Neuraxpharm is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders. | Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. | EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients). | |
Founding Date | Founding Date 1985 | Founding Date 2005 | Founding Date 1964 | Founding Date 1907 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Langenfeld (Rheinland), DE HQ Gießhübl, AT Hradec Králové, CZ Paris, FR Budapest, HU Dublin, IE Ascoli Piceno, IT see more | Locations Rockville, US HQ | Locations BR HQ | Locations Vadodara, IN HQ Mumbai, IN Vadodara, IN |
Employees | Employees 7002% increase | Employees 6527% increase | Employees 12,825 | Employees 14,858 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $607.5m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) ₹61.1b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $83.8m (FY, 2023) | Cost of goods N/A | Cost of goods ₹19.3b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $523.7m (FY, 2023) | Gross profit N/A | Gross profit ₹43b (FY, 2024) |
Net income | Net income N/A | Net income $1.3m (FY, 2023) | Net income N/A | Net income ₹6.2b (FY, 2024) |